News

Ultragenyx’s GTX-102 Receives FDA Breakthrough Therapy Designation for Angelman Syndrome
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) is one of the most promising stocks according to Wall Street analysts. On June ...